- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
364 |
PAVAN BRAHMAMDAM, JARED T. MUENZER, RICHARD S. HOTCHKISS, AND JONATHAN E. MCDUNN |
||||
|
|
|
|
ent features of apoptotic cells: (1) histologic eval- |
|
|
Table 31-1. Mechanisms of immune dysfunction |
|
|||
|
|
uation of hematoxylin/eosin-stained tissue sections |
|||
|
|
|
|
||
|
Apoptosis of T cells, B cells, dendritic cells and monocytes |
|
revealed characteristic pyknotic nuclei and karyorrhexis, |
||
|
TH1 → TH2 phenotype |
|
|
(2) fluorescent terminal deoxynucleotidyl transferase |
|
|
Anergy |
|
|
dUTP nick end labeling (TUNEL) staining demonstrated |
|
|
Increased proportion of T-regulatory cells |
|
|||
|
|
systematic genomic degradation subsequent to poly |
|||
|
Increased anti-inflammatory mediators |
|
|||
|
|
(ADP-ribose) polymerase activation, and (3) immuno- |
|||
|
Loss of macrophage expression of MHC-II and costimulatory |
|
|||
|
|
histochemical staining identified the active form of the |
|||
|
molecules |
|
|
||
|
Deactivated monocytes |
|
|
executioner caspase, caspase-3. Light microscopy fur- |
|
|
|
|
|
ther revealed massive loss of lymphocytes and disrup- |
|
|
MHC, major histocompatibility complex. |
|
|||
|
|
tion of germinal center architecture from the spleens of |
|||
|
|
|
|
||
|
|
|
|
||
histocompatibility complex II expression,15,16,17 increase |
septic patients compared with nonseptic controls. Sub- |
||||
in anti-inflammatory mediators,18 decreased monocyte |
sequent studies revealed that the cells that were depleted |
||||
expression of human leukocyte antigen type DR,7 and |
during sepsis were CD4+ T cells, B cells, and follicu- |
||||
the apoptotic loss of lymphocytes, dendritic cells, and |
lar and interdigitating dendritic cells.20,21 Septic patients |
||||
were also found to have decreased circulating lympho- |
|||||
gastrointestinal epithelial cells6 (Table 31-1). Immuno- |
|||||
suppressed patients fail to clear their primary infections |
cyte counts compared with nonseptic patients. Immune |
||||
cell apoptosis in septic patients has been demonstrated |
|||||
and are susceptible to secondary infections, either noso- |
|||||
in subsequent autopsy studies in both children and |
|||||
comial or opportunistic; survival is correlated with the |
|||||
neonates.22,23 |
|||||
|
|
7 |
|
||
ability to maintain or restore immune competence. |
Septic patients have a marked increase in apopto- |
||||
|
|
|
|
||
3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS |
sis of circulating lymphocytes when compared with crit- |
||||
ically ill nonseptic patients.24 Apoptosis leads to lym- |
|||||
|
|
|
|
||
3.1. Sepsis-induced apoptosis |
phopenia that is persistent in septic patients, and the |
||||
degree of apoptosis is positively correlated with the |
|||||
|
|
|
|
||
Sepsis-induced apoptotic cell death was first character- |
severity of sepsis and with poor outcome. Recent stud- |
||||
ized in a study in which autopsies were conducted in |
ies looking at immune cells from septic patients found |
||||
critically ill patients who died of either sepsis or non– |
significant upregulation of the messenger RNA for the |
||||
septic-related etiologies.19 |
Autopsies |
|
|||
were performed in the intensive care |
|
||||
units 30 to 90 minutes postmortem |
|
||||
to avoid cell autolysis after death. |
|
||||
The causes of sepsis were multifacto- |
|
rial, with a predominance of patients having nosocomial pneumonia. Most patients suffered from multiorgan system failure and experienced extended periods of hypotension requiring vasopressor treatment. Patients who died from sepsis had extensive apoptotic death of splenic lymphocytes and gastrointestinal epithelial cells compared with critically ill patients who died from nonseptic causes (Figures 31-1 and 31-2). Other organs, including lung, kidney, and skeletal muscle, did not reveal consistent apoptosis or necrosis despite a majority of patients exhibiting multiorgan dysfunction.
Apoptosis was detected by three dif- |
Figure 31-1. Lymphocyte apoptosis in spleen of septic patient. Hematoxylin and eosin stain- |
|
ing of spleen of septic patient (400× magnification). Note the abnormal, pyknotic nuclei and |
||
ferent techniques that identify differ- |
||
nuclear debris characteristic of apoptotic cells (arrows). See Color Plate 35. |
APOPTOTIC CELL DEATH IN SEPSIS |
|
|
365 |
|
|
|
and were requiring vasopressors to |
||
|
|
maintain an adequate arterial blood |
||
|
|
pressure. The area of the liver that |
||
|
|
demonstrated necrotic changes was the |
||
|
|
region approximating the central vein. |
||
|
|
This region is vulnerable to hypoxia |
||
|
|
and decreased flow because of its |
||
|
|
unique perfusion. Thus the hepatocyte |
||
|
|
necrosis may have been secondary to |
||
|
|
hypotension and hypoxia in the setting |
||
|
|
of sepsis. Necrotic cell death was also |
||
|
|
seen in the brain and heart of three |
||
|
|
patients. However, these patients had |
||
|
|
evidence of prior cerebrovascular inci- |
||
|
|
dents or myocardial infarction. |
||
|
|
Although these studies did not con- |
||
|
|
clusively link sepsis to necrotic cell |
||
Figure 31-2. Colonic epithelial apoptosis in a septic patient. Hematoxylin and eosin staining |
death, there was unquestionable necro- |
|||
sis within |
hypoxia-sensitive tissues. |
|||
of colonic epithelium of a septic patient (400× magnification). Arrows point to apoptotic cells |
||||
This necrosis could be explained by |
||||
being shed into the lumen of the colon. See Color Plate 36. |
|
|||
|
|
ischemia-reperfusion injury, as there is |
||
|
|
well-documented microvascular patho- |
||
proapoptotic genes Bid, Bim, and Bak and downregula- |
logy in sepsis; however, the role of necrosis in sepsis |
|||
tion of BCL-2.25 |
remains poorly understood. |
|||
In addition to the hematopoietic compartment, the |
|
|
|
|
gastrointestinal epithelium has long been a focus of |
4. THE DEVELOPMENT OF CLINICALLY RELEVANT |
|||
study in sepsis research, and the gut has even been |
||||
ANIMAL MODELS OF SEPSIS |
|
|||
referred to as the “motor” of the immune system.26 The |
|
|||
|
|
|
||
lining of the gastrointestinal tract “turns over” every 3 |
Early animal models of sepsis, on which previous re- |
|||
to 5 days and is a function of the balance between cell |
search and therapies were based, involved lipo- |
|||
death and proliferation. Maintenance of this barrier is |
polysaccharide challenge |
(intravenous, intratracheal, |
||
important in preventing translocation of live bacteria |
or intraperitoneal).27 These models defined the classic |
|||
or bacterial toxins. The aforementioned autopsy study |
proinflammatory phase of sepsis, characterized by |
|||
identified the increased incidence of colonic epithelial |
tachycardia, tachypnea, hypotension, and high levels |
|||
apoptosis in both the villi and crypts in septic patients |
systemic of TNF-α, IL-1, IL-6, and interferon (IFN)-γ, |
|||
compared with nonseptic patients (Figure 31-2).19 Apop- |
and anti-inflammatory interventions in these models |
|||
tosis of epithelial cells was also seen in the ileum of septic |
resulted in significant gains in survival. Unfortunately, |
|||
patients. Gastrointestinal epithelial apoptosis may lead |
anti-inflammatory strategies based on these models |
|||
to breakdown of this important barrier, resulting in sys- |
failed to provide significant mortality benefit to the |
|||
temic leakage of endogenous flora. |
general septic population.1 Failure of these therapies |
|||
|
led to development of more clinically relevant models |
|||
3.2. Necrotic cell death in sepsis |
of sepsis. The cecal-ligation and puncture (CLP) model |
|||
was developed to mimic sepsis owing to a ruptured |
||||
|
||||
These autopsy studies also revealed necrotic cell death |
appendix or bowel perforation.28 Pneumonia models |
|||
in other organ systems in patients who died with sep- |
use bacteria commonly found to cause pneumonia, |
|||
sis.19 Microscopic evidence of necrosis in the liver was |
such as Pseudomonas aeruginosa or Streptococcus pneu- |
|||
identified in approximately 33% of patients. Interest- |
moniae.29 Pneumonia after CLP – or “two-hit” – models |
|||
ingly, apoptotic hepatocytes were seen in some patients |
of sepsis mimic clinical scenarios involving secondary, |
|||
with identified necrosis, and the apoptosis occurred in |
or nosocomial, infections.30 |
|
||
proximity to necrotic foci. It is important to note that |
The identification of immune cell and gastrointesti- |
|||
almost all of the patients with sepsis were in septic shock |
nal epithelial apoptosis in septic patients led researchers |
366 |
PAVAN BRAHMAMDAM, JARED T. MUENZER, RICHARD S. HOTCHKISS, AND JONATHAN E. MCDUNN |
to investigate whether clinically relevant models of sepsis also exhibited these findings. Animal models have provided important insights into the role of apoptosis in the pathophysiology of and mortality from sepsis.
4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
The balance between proand antiapoptotic proteins, especially Bcl-2 and its family members, regulates apoptotic cell death.31,32,33 Experiments using transgenic mice have provided mechanistic insights into the role of apoptosis in sepsis lethality. Mice over-expressing Bcl-2 in T and B lymphocytes are resistant to sepsis-induced lymphocyte apoptosis and have improved survival after cecal ligation and puncture when compared with wildtype mice.34,35 Mice over-expressing Bcl-2 in the gastrointestinal epithelium have decreased gut epithelial apoptosis and improved survival in a model of Pseudomonas pneumonia.36 Sepsis probably creates an environment that accelerates death of gut epithelial cells that are predestined to die and initiates the apoptotic machinery in other cells. During pneumonia there is a disassociation between apoptotic cell death and cellular regeneration and a large number of intestinal epithelial cells undergo apoptosis, but there is not a compensatory increase in gut epithelial cell proliferation.37 These studies, along with research delineating apoptotic pathways (vide infra), highlight the significant role of apoptotic cell death in sepsis.
4.2. Apoptotic pathways in sepsis-induced immune cell death
Apoptosis in mammalian cells is mediated through two different pathways.31 The extrinsic, or death receptor, pathway is activated by a number of death receptor ligands, including TNF-α, TNF-related apoptosisinducing ligand (TRAIL), and Fas ligand and act through the death-inducing signaling complex (DISC), which activates the initiator caspase, caspase-8. The intrinsic, or mitochondrial-mediated, pathway can be activated by a large number of stimuli, including oxidative stress, radiation, cytochrome c, cytokine withdrawal, and chemotherapeutic agents. Activation of this pathway results in formation of the apoptosome (a macromolecular assembly of apoptotic protease activating factor 1, cytochrome c, and pro-caspase-9), which activates the initiator caspase, caspase-9. Once activated, caspase-8 and caspase-9 can cleave the executioner caspase, caspase-3, which in turn activates a cascade of
proteases and endonucleases that results in the systematic disassembly of the cell. Current evidence suggests that both pathways are involved in sepsis-induced lymphocyte apoptosis.38
4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
A key protein in the assembly of the DISC is the Fasassociated death domain (FADD). Mice that express a dominant-negative form of FADD in T cells are protected from T- and B-cell apoptosis and have increased survival compared with wild-type mice in the CLP model of sepsis.39 Mice deficient in Fas ligand have decreased B-cell apoptosis during sepsis. Inhibition of Fas/FasL signaling has been shown to increase survival in sepsis and prevented loss of macrophages.40 Apoptosis in CD4 T-cell populations can also be mediated by FasL during polymicrobial sepsis.41 These results points to the multiplicity of death stimuli that are likely involved in sepsis-induced apoptosis via the extrinsic pathway. FADD integrates a large number of these signals, and therefore, removing its function is broadly protective; although removing a single ligand or receptor that signals through FADD can attenuate apoptosis, no single ligand/receptor pair studied phenocopies the survival advantage in FADD-DN mice. Interestingly, deletion of MyD88, another significant integrating node in the immune system that transduces pathogen sensing by Toll-like receptors, leads to amelioration of T- and B- cell apoptosis owing to sepsis but worsened survival in a CLP model of sepsis.42 These results indicate that certain classes of signal are essential for engaging the immune system, whereas other classes of signal molecules are detrimental. Mice deficient for MyD88 had essentially no cytokine production in sepsis and were therefore unable to respond to their infection.
4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
The mitochondrial pathway is activated by multiple stimuli and is mediated by the Bcl-2 family of proteins.33 The Bcl-2 family of proteins includes more than 15 members and comprises both antiapoptotic and proapoptotic members. Bcl-2, which was characterized first, is known to function primarily as an inhibitor of apoptosis. Studies in both cancer and sepsis have used Bcl-2 to modulate apoptosis.33 The importance of this protection in sepsis was first demonstrated by our laboratory in studies showing that transgenic over-expression of Bcl-2 in lymphocytes decreased immune effector cell apoptosis